Cargando…

Silencing of NOD2 protects against diabetic cardiomyopathy in a murine diabetes model

The aim of the present study was to investigate the role of the nucleotide-binding oligomerization domain (NOD) 2 in high glucose (HG)-induced myocardial apoptosis and fibrosis in mice. Mouse models of diabetes were induced by streptozotocin (STZ). NOD2 expression was knocked down by injection of le...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Lin, Li, Li, Li, Man, Wang, Weiling, Yin, Wenbin, Liu, Wei, Hu, Yanyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202090/ https://www.ncbi.nlm.nih.gov/pubmed/30221681 http://dx.doi.org/10.3892/ijmm.2018.3880

Ejemplares similares

Replacing murine insulin 1 with human insulin protects NOD mice from diabetes
por: Elso, Colleen M., et al.
Publicado: (2019)

Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats
por: Liu, Wenjuan, et al.
Publicado: (2018)

Human milk oligosaccharides protect against the development of autoimmune diabetes in NOD-mice
por: Xiao, Ling, et al.
Publicado: (2018)

Dihydromyricetin Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Mice
por: Wu, Bin, et al.
Publicado: (2017)

Cyclovirobuxine D protects against diabetic cardiomyopathy by activating Nrf2-mediated antioxidant responses
por: Jiang, Zhaohui, et al.
Publicado: (2020)

Characterising an Alternative Murine Model of Diabetic Cardiomyopathy
por: Tate, Mitchel, et al.
Publicado: (2019)

TRB3 Gene Silencing Alleviates Diabetic Cardiomyopathy in a Type 2 Diabetic Rat Model
por: Ti, Yun, et al.
Publicado: (2011)

NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model
por: Luo, Beibei, et al.
Publicado: (2014)

Axenic Caenorhabditis elegans antigen protects against development of type-1 diabetes in NOD mice
por: Jackson-Thompson, Belinda M., et al.
Publicado: (2020)

Corrigendum: Characterising an Alternative Murine Model of Diabetic Cardiomyopathy
por: Tate, Mitchel, et al.
Publicado: (2021)

Activating Cannabinoid Receptor 2 Protects Against Diabetic Cardiomyopathy Through Autophagy Induction
por: Wu, Aiping, et al.
Publicado: (2018)

MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin
por: Dai, Beibei, et al.
Publicado: (2018)

PTPN22 Silencing in the NOD Model Indicates the Type 1 Diabetes–Associated Allele Is Not a Loss-of-Function Variant
por: Zheng, Peilin, et al.
Publicado: (2013)

Emodin Protects against Diabetic Cardiomyopathy by Regulating the AKT/GSK-3β Signaling Pathway in the Rat Model
por: Wu, Zhiqin, et al.
Publicado: (2014)

Myocardial protection of S-nitroso-L-cysteine in diabetic cardiomyopathy mice
por: Peng, Lulu, et al.
Publicado: (2022)

Cardiomyocyte GTP Cyclohydrolase 1 Protects the Heart Against Diabetic Cardiomyopathy
por: Wu, Hsiang-En, et al.
Publicado: (2016)

Glibenclamide Prevents Diabetes in NOD Mice
por: Lamprianou, Smaragda, et al.
Publicado: (2016)

The NOD Mouse Beyond Autoimmune Diabetes
por: Aubin, Anne-Marie, et al.
Publicado: (2022)

Pyridostigmine Protects Against Diabetic Cardiomyopathy by Regulating Vagal Activity, Gut Microbiota, and Branched-Chain Amino Acid Catabolism in Diabetic Mice
por: Yang, Yang, et al.
Publicado: (2021)

Pemafibrate Protects Against Retinal Dysfunction in a Murine Model of Diabetic Retinopathy
por: Tomita, Yohei, et al.
Publicado: (2020)

Prevention of Autoimmune Diabetes in NOD Mice by Dimethyl Fumarate
por: Li, Shiri, et al.
Publicado: (2021)

MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα
por: Yin, Zhongwei, et al.
Publicado: (2019)

Myricitrin Alleviates Oxidative Stress-induced Inflammation and Apoptosis and Protects Mice against Diabetic Cardiomyopathy
por: Zhang, Bin, et al.
Publicado: (2017)

Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse
Publicado: (1987)

Ginsenoside Rb1 Protects Against Diabetic Cardiomyopathy by Regulating the Adipocytokine Pathway
por: Zhang, Chenyang, et al.
Publicado: (2022)

LncRNA H19 inhibits autophagy by epigenetically silencing of DIRAS3 in diabetic cardiomyopathy
por: Zhuo, Chuanjun, et al.
Publicado: (2016)

Resveratrol and Diabetic Cardiomyopathy: Focusing on the Protective Signaling Mechanisms
por: Song, Yan-Jun, et al.
Publicado: (2020)

Role of NOD-Like Receptors in a Miniature Pig Model of Diabetic Renal Injuries
por: Ren, Yi, et al.
Publicado: (2022)

Oligofructose as an adjunct in treatment of diabetes in NOD mice
por: Chan, Clement, et al.
Publicado: (2016)

Mapping the cellular and molecular landscape of cardiac non-myocytes in murine diabetic cardiomyopathy
por: Cohen, Charles D., et al.
Publicado: (2023)

BNP protects against diabetic cardiomyopathy by promoting Opa1-mediated mitochondrial fusion via activating the PKG-STAT3 pathway
por: Chang, Pan, et al.
Publicado: (2023)

Paquinimod prevents development of diabetes in the non-obese diabetic (NOD) mouse
por: Tahvili, Sahar, et al.
Publicado: (2018)

Nesfatin-1 protects against diabetic cardiomyopathy in the streptozotocin-induced diabetic mouse model via the p38-MAPK pathway
por: Fan, Zhanwei, et al.
Publicado: (2022)

Oral delivery of bi-autoantigens by bacterium-like particles (BLPs) against autoimmune diabetes in NOD mice
por: Mao, Ruifeng, et al.
Publicado: (2023)

NOD2 Deficiency Promotes Intestinal CD4+ T Lymphocyte Imbalance, Metainflammation, and Aggravates Type 2 Diabetes in Murine Model
por: Carlos, Daniela, et al.
Publicado: (2020)

Exercise protects against diabetic cardiomyopathy by the inhibition of the endoplasmic reticulum stress pathway in rats
por: Chengji, Wang, et al.
Publicado: (2018)

The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy
por: Waldman, Maayan, et al.
Publicado: (2019)

Panax notoginseng Saponin Protects Against Diabetic Cardiomyopathy Through Lipid Metabolism Modulation
por: Zhang, Chenyang, et al.
Publicado: (2022)

Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy
por: Yang, Fan, et al.
Publicado: (2018)

Investigation of the Protective Effects of Phlorizin on Diabetic Cardiomyopathy in db/db Mice by Quantitative Proteomics
por: Cai, Qian, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8bhep6nt0eivc1n9vsvjh8t20g